CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 237 filers reported holding CLOVIS ONCOLOGY INC in Q1 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,478,000 | -37.4% | 30,073 | -28.9% | 0.33% | -49.8% |
| Q2 2017 | $3,960,000 | +7.5% | 42,294 | -26.9% | 0.66% | +12.7% |
| Q1 2017 | $3,685,000 | +26.5% | 57,882 | +82.7% | 0.58% | +26.0% |
| Q3 2015 | $2,913,000 | -31.1% | 31,678 | -34.1% | 0.46% | -6.9% |
| Q2 2015 | $4,227,000 | +332.7% | 48,096 | +229.8% | 0.50% | +133.5% |
| Q2 2013 | $977,000 | – | 14,584 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |